Form 8-K ANI PHARMACEUTICALS INC For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook
August 4, 2016 8:43 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.11, $0.34 better than the analyst estimate of $0.77. Revenue for the quarter came in at $31.34 million versus the consensus estimate of $27.63 million.
GUIDANCE:
ANI Pharma sees FY2016 EPS of $4.00-$4.25, versus the consensus... More
